These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7916042)

  • 1. Primary therapy of Waldenstrom's macroglobulinemia with paclitaxel.
    Dimopoulos MA; Luckett R; Alexanian R
    J Clin Oncol; 1994 Sep; 12(9):1998. PubMed ID: 7916042
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Chlorodeoxyadenosine treatment of Waldenström's macroglobulinemia--the analysis of own experience and the review of literature.
    Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Hellmann A
    Med Sci Monit; 2000; 6(4):740-5. PubMed ID: 11208402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgenic therapy for Waldenstrom's macroglobulinemia.
    Porrata LF; Markovic SN
    Am J Hematol; 2006 Nov; 81(11):892-3. PubMed ID: 16783787
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.
    Delannoy A; Ferrant A; Martiat P; Bosly A; Zenebergh A; Michaux JL
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):317-20. PubMed ID: 7971252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
    Hałaburda K; Hellmann A
    Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present state of therapy of myeloma and Waldenström's macroglobulinemic lymphoreticulosis].
    Grifoni V; Bignotti G; Tognella S; Scaltrini G
    Recenti Prog Med; 1965 Oct; 39(4):415-36. PubMed ID: 4955116
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia.
    Zaucha JM; Ciesielski D; Grieb P; Hellmann A
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):35-7. PubMed ID: 7503632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of Waldenstrom's macroglobulinemia].
    Mokeeva RA
    Sov Med; 1973 Aug; 36(8):32-8. PubMed ID: 4204704
    [No Abstract]   [Full Text] [Related]  

  • 11. Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia.
    Noronha V; Fynan TM; Duffy T
    J Clin Oncol; 2006 Jan; 24(1):e3. PubMed ID: 16382111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Waldenstrom's macroglobulinemia with therapy-resistant meningeosis and involvement of the central nervous system].
    Lange J; Willmanns W; Seybold G; Wegner G
    Verh Dtsch Ges Inn Med; 1975; 81():1612-5. PubMed ID: 818842
    [No Abstract]   [Full Text] [Related]  

  • 13. [Respiratory forms of Waldenstrom's macroglobulinemia].
    Bollinelli R; Carles P; de Boissezon JF; Biermé R; Pujol M
    J Fr Med Chir Thorac; 1970; 24(4):437-80. PubMed ID: 5005096
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
    Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
    Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Waldenström's macroglobulinemia effectively treated with chronic daily oral administration of low-dose etoposide].
    Itoh K; Shimada T; Horibe T; Kawai N; Sakata T; Fukuda M; Murohashi I; Bessho M; Takeuchi H; Hirashima K
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2131-4. PubMed ID: 9838919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
    Treon SP; Soumerai JD; Branagan AR; Hunter ZR; Patterson CJ; Ioakimidis L; Chu L; Musto P; Baron AD; Nunnink JC; Kash JJ; Terjanian TO; Hyman PM; Nawfel EL; Sharon DJ; Munshi NC; Anderson KC
    Clin Cancer Res; 2009 Jan; 15(1):355-60. PubMed ID: 19118065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Waldenstrom's macroglobulinemia with "deck-chair" sign treated with cyclophosphamide.
    Autier J; Buffet M; Pinquier L; Merlat-Guitard AI; Carlotti A; Franck N; Gorin I; Dupin N
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):45-7. PubMed ID: 15692513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.
    Ngan S; Rohatiner AZ; Matthews J; Williams A; Amess JA; Norton A; Lister TA
    Semin Oncol; 2003 Apr; 30(2):236-8. PubMed ID: 12720143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of resistant Waldenstrom's macroglobulinemia with high dose glucocorticosteroids.
    Jane SM; Salem HH
    Aust N Z J Med; 1988 Feb; 18(1):77-8. PubMed ID: 3134882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Remission of clinical symptoms in a case of Waldenström's disease treated with indomethacin].
    De Martiis M; Fontana M; Venditti A
    Clin Ter; 1971 Dec; 59(5):451-8. PubMed ID: 5003584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.